One notable mechanism involves the upregulation of upstream effectors like insulin-like growth factor receptor (IGF-1R) when PI3K is inhibited, leading to insulin feedback and transient hyperglycemia (Figure 2). Here, PIK3CB is linked to Hyperglycemia.